Absorption |
Blood-Brain Barrier | BBB- | 0.9836 |
Human Intestinal Absorption | HIA+ | 0.8344 |
Caco-2 Permeability | Caco2- | 0.5704 |
P-glycoprotein Substrate | Substrate | 0.9098 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7651 |
Non-inhibitor | 0.8950 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9175 |
Distribution |
Subcellular localization | Nucleus | 0.5496 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8283 |
CYP450 2D6 Substrate | Non-substrate | 0.8323 |
CYP450 3A4 Substrate | Substrate | 0.7170 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8705 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8820 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9079 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8592 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9271 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8863 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9926 |
Non-inhibitor | 0.6739 |
AMES Toxicity | Non AMES toxic | 0.7290 |
Carcinogens | Non-carcinogens | 0.8718 |
Fish Toxicity | High FHMT | 0.9736 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9704 |
Honey Bee Toxicity | Low HBT | 0.6573 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.6764 |
Carcinogenicity (Three-class) | Non-required | 0.6660 |